LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 2.65 USD -1.85%
Updated: May 22, 2024

LAVA Therapeutics NV
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LAVA Therapeutics NV
Tax Provision Peer Comparison

Comparables:
PHARM
QURE
ARGX
MRUS
N
NAMS

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Tax Provision
-$279k
CAGR 3-Years
-91%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Tax Provision
$1.5m
CAGR 3-Years
N/A
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Tax Provision
-$3.8m
CAGR 3-Years
N/A
CAGR 5-Years
-57%
CAGR 10-Years
N/A
argenx SE
XBRU:ARGX
Tax Provision
$32.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Tax Provision
-$4.7m
CAGR 3-Years
-118%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
N
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Tax Provision
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is LAVA Therapeutics NV's Tax Provision?
Tax Provision
-279k USD

Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Tax Provision amounts to -279k USD.

What is LAVA Therapeutics NV's Tax Provision growth rate?
Tax Provision CAGR 3Y
-91%

Over the last year, the Tax Provision growth was -12%. The average annual Tax Provision growth rates for LAVA Therapeutics NV have been -91% over the past three years .